Bemiparin Versus Unfractionated Heparin as Bridging Therapy in the Perioperative Management of Patients on Vitamin K Antagonists: The BERTA Study

Santamaría, Amparo; Ugarriza, Aránzazu; Muñoz, Carmen; Diego, Isabel de; López-Chuliá, Francisca; Benet, Carmen; Martínez, Javier; Gomez, N.; Piña, Elena Carrasco; Ortı́n, Xavier; Marco, Pascual; Roncalés, F.; Fontcuberta, Jordi

doi:10.1007/s40261-013-0141-6

Cited by 8 publications

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…По-третє, для дабігатра-ну відсутній антидот. Були отримані дані про те, що використання концентрату протромбінового комп-лексу призводить до нівелювання дії ривароксабану в здорових добровольців [10]. Насамперед слід оці-нити ризик розвитку кровотеч, пов'язаний із пев-ним типом оперативного втручання і певним типом анестезії, наприклад спинномозкової.…”

Section: íìã ï³äøê³ðíîunclassified

Застосування Принципів Бриджинг-Терапії При Супутній Гострій Печінковій Недостатності

et al. 2022

View full text Add to dashboard Cite

show abstract

Section: íìã ï³äøê³ðíîunclassified

Застосування Принципів Бриджинг-Терапії При Супутній Гострій Печінковій Недостатності

et al. 2022

View full text Add to dashboard Cite

show abstract

Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients

Junqueira

Zorzela

Perini

2017

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

This updated review demonstrated low-quality evidence of a lower incidence of HIT, and HIT complicated by venous thromboembolism, in postoperative patients undergoing thromboprophylaxis with LMWH compared with UFH. Similarily, the risk of HIT in people undergoing major surgical procedures was lower when treated with LMWH compared to UFH (low-quality evidence). The quality of the evidence was downgraded due to concerns about the risk of bias in the included studies and imprecision of the study results. These findings may support current clinical use of LMWH over UFH as front-line heparin therapy. However, our conclusions are limited and there was an unexpected paucity of RCTs including HIT as an outcome. To address the scarcity of clinically-relevant information on HIT, HIT must be included as a core harmful outcome in future RCTs of heparin.

show abstract

Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review

Baumgartner

Kouchkovsky

Whitaker

et al. 2019

The American Journal of Medicine

View full text Add to dashboard Cite

Periprocedural bridging is widely used in patients with previous venous thromboembolism who require interruption of vitamin K antagonists due to an invasive procedure  This systematic review found that periprocedural bridging in patients with previous venous thromboembolism increases the risk of bleeding without reducing the risk of periprocedural venous thromboembolism  Most patients with venous thromboembolism do not benefit from periprocedural bridging

show abstract

Bemiparin Versus Unfractionated Heparin as Bridging Therapy in the Perioperative Management of Patients on Vitamin K Antagonists: The BERTA Study

Cited by 8 publications

References 28 publications

Застосування Принципів Бриджинг-Терапії При Супутній Гострій Печінковій Недостатності

Застосування Принципів Бриджинг-Терапії При Супутній Гострій Печінковій Недостатності

Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients

Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review

Contact Info

Product

Resources

About